NCT03045926View on ClinicalTrials.gov

Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

May 9, 2017

Study Completion Date

May 9, 2017

Conditions
Chronic Functional Diarrhea of Unknown Origin
Interventions
DRUG

Diosmectite (Smecta®)

Trial Locations (2)

9728NZ

PRA Health Sciences, Groningen

M13 9NQ

MAC Clinical Research Limited, Manchester

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY